HomeACADEMIA
ACADEMIA

Over 150 Clinical Trials of Epigenetic Drugs, Some with Novel Mechanisms of Action, Underway Worldwide
(Aug.31.2017)

The development of epigenetic drugs, which show promise as new treatments for cancer and other diseases, is gaining momentum. More than 150 clinical trials of such drugs, including some with novel mechanisms of action and some that target solid cancers, are underway worldwide, revealed Toshikazu Ushijima, chief of the Division of Epigenomics, National Cancer Center Research Institute, in an interview with Jiho ...
(LOG IN FOR FULL STORY)

News Calendar